Equillium (EQ) Research & Development (2018 - 2026)

Equillium (EQ) has 9 years of Research & Development data on file, last reported at $3.0 million in Q1 2026.

• Research & Development for Q1 2026 came in at $3.0 million, down 49.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (down 56.76% YoY), and the FY2025 annual result was $12.8 million, down 65.69% from the prior year.
• Research & Development improved to $3.0 million in Q1 2026 per EQ's latest filing, from $1.5 million in the prior quarter.
• Over five years, Research & Development peaked at $10.8 million in Q2 2024 and troughed at $400000.0 in Q3 2025.
• A 5-year average of $7.5 million and a median of $9.0 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2025: Research & Development soared 83.04% in 2022, then plunged 95.82% in 2025.
• A 5-year view of Research & Development shows it stood at $8.5 million in 2022, then climbed by 7.73% to $9.2 million in 2023, then retreated by 20.35% to $7.3 million in 2024, then slumped by 79.0% to $1.5 million in 2025, then jumped by 94.73% to $3.0 million in 2026.
• Business Quant data shows EQ's Research & Development at $3.0 million in Q1 2026, $1.5 million in Q4 2025, and $400000.0 in Q3 2025.